-
Company Insights
Innovation and Patenting activity of GNI Group Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of GNI Group Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
Pulmonary Radiation Toxicity – Drugs In Development, 2023
Global Markets Direct’s, ‘Pulmonary Radiation Toxicity - Drugs In Development, 2023’, provides an overview of the Pulmonary Radiation Toxicity pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pulmonary Radiation Toxicity , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally,...
-
Product Insights
Acute Promyelocytic Leukemia – Drugs In Development, 2023
Global Markets Direct’s, ‘Acute Promyelocytic Leukemia - Drugs In Development, 2023’, provides an overview of the Acute Promyelocytic Leukemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acute Promyelocytic Leukemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Acute On Chronic Liver Failure (ACLF) – Drugs In Development, 2023
Global Markets Direct’s, ‘Acute On Chronic Liver Failure (ACLF) - Drugs In Development, 2023’, provides an overview of the Acute On Chronic Liver Failure (ACLF) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acute On Chronic Liver Failure (ACLF), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development...
-
Product Insights
Pleural Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Pleural Disease - Drugs In Development, 2023’, provides an overview of the Pleural Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pleural Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Dermatomyositis – Drugs In Development, 2023
Global Markets Direct’s, ‘Dermatomyositis - Drugs In Development, 2023’, provides an overview of the Dermatomyositis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Dermatomyositis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Acute Liver Failure – Drugs In Development, 2023
Global Markets Direct’s, ‘Acute Liver Failure - Drugs In Development, 2023’, provides an overview of the Acute Liver Failure pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acute Liver Failure, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease) – Drugs In Development, 2023
Global Markets Direct’s, ‘Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease) - Drugs In Development, 2023’, provides an overview of the Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete...
-
Product Insights
Liver Failure (Hepatic Insufficiency) – Drugs In Development, 2023
Global Markets Direct’s, ‘Liver Failure (Hepatic Insufficiency) - Drugs In Development, 2023’, provides an overview of the Liver Failure (Hepatic Insufficiency) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Liver Failure (Hepatic Insufficiency), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...